source
- Pfizer CEO says $7 billion cash ready for bolt‑on acquisitions and dividend will stay intactDuring its second‑quarter earnings call, analysts asked Pfizer if the company would increase M&A spending as rivals rush to buy biotech assets. CEO Albert Bourla replied that Pfizer currently has…
- Fresenius Kabi recalls one lot of Morphine Sulfate Injection after labeling error mixes Dilaudid syringesFresenius Kabi announced a voluntary recall of a single lot of its Morphine Sulfate Injection USP, Simplist 2 mg/1 mL product. The recall stems from a labeling mistake where the MicroVault contain…